Company intelligence

Decoy Therapeutics

BiotechActive

Is this your company? Get featured or correct your listing →

Suggest a correction

We're still building this profile — here is what Pulse has covered.

Recent changes

  1. Jul 10, 2026Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE Pulse story

Latest Pulse

  1. Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPEDecoy Therapeutics filed its second S-1 in a month tied to a private placement that could deliver up to $21 million in milestone-based warrant proceeds contingent on trial results and shareholder approval.→

Coverage Timeline

newest first
  1. Jul 10, 2026IPODecoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE~$3.5M base + up to $21M contingent→

All Coverage

IPO

Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE

Illustration for: Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE
IPO~$3.5M base + up to $21M contingent

Decoy Therapeutics Files S-1 Amid $21M Milestone-Based PIPE

Decoy Therapeutics filed its second S-1 in a month tied to a private placement that could deliver up to $21 million in milestone-based warrant proceeds contingent on trial results and shareholder approval.

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsIambic TherapeuticsApnimedRetension PharmaceuticalsEli Lilly